30+ years of pharmaceutical, biotech, and academic experience in preclinical and early clinical research with main focus in oncology. Tenure at Rhône-Poulenc, Aventis and Sanofi, with leadership executive roles; contributed to five approved drugs. Spent 10 years in Biotech as Chief Scientific Officer and Chief Development Officer, at Genticel and Novintum. Consulted for VC and Private Equity. Holds a PhD in Pharmaceutical Sciences and a Doctorate in Pharmacy from University of Paris XI, France. Has published and patented extensively.